Literature DB >> 19878875

p53-dependent translational control of senescence and transformation via 4E-BPs.

Emmanuel Petroulakis1, Armen Parsyan, Ryan J O Dowling, Olivier LeBacquer, Yvan Martineau, Michael Bidinosti, Ola Larsson, Tommy Alain, Liwei Rong, Yaël Mamane, Marilene Paquet, Luc Furic, Ivan Topisirovic, David Shahbazian, Mark Livingstone, Mauro Costa-Mattioli, Jose G Teodoro, Nahum Sonenberg.   

Abstract

eIF4E, the mRNA 5' cap-binding translation initiation factor, is overexpressed in numerous cancers and is implicated in mechanisms underlying oncogenesis and senescence. 4E-BPs (eIF4E-binding proteins) inhibit eIF4E activity, and thereby act as suppressors of eIF4E-dependent pathways. Here, we show that tumorigenesis is increased in p53 knockout mice that lack 4E-BP1 and 4E-BP2. However, primary fibroblasts lacking 4E-BPs, but expressing p53, undergo premature senescence and resist oncogene-driven transformation. Thus, the p53 status governs 4E-BP-dependent senescence and transformation. Intriguingly, the 4E-BPs engage in senescence via translational control of the p53-stabilizing protein, Gas2. Our data demonstrate a role for 4E-BPs in senescence and tumorigenesis and highlight a p53-mediated mechanism of senescence through a 4E-BP-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878875     DOI: 10.1016/j.ccr.2009.09.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

1.  Escherichia coli succinic thiolinase. Stoichiometry of phosphorylation and coenzyme A binding.

Authors:  C M Bowman; J S Nishimura
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Authors:  Paige Yellen; Mahesh Saqcena; Darin Salloum; Jiangnan Feng; Angela Preda; Limei Xu; Vanessa Rodrik-Outmezguine; David A Foster
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 3.  Translational regulation in nutrigenomics.

Authors:  Botao Liu; Shu-Bing Qian
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

4.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

Authors:  T L Ng; G Leprivier; M D Robertson; C Chow; M J Martin; K R Laderoute; E Davicioni; T J Triche; P H B Sorensen
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

5.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

6.  Identification of differential translation in genome wide studies.

Authors:  Ola Larsson; Nahum Sonenberg; Robert Nadon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

7.  Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis.

Authors:  Veronique Nogueira; Deepa Sundararajan; Jennifer M Kwan; Xiao-ding Peng; Neha Sarvepalli; Nahum Sonenberg; Nissim Hay
Journal:  EMBO J       Date:  2012-02-03       Impact factor: 11.598

8.  mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.

Authors:  Ryan J O Dowling; Ivan Topisirovic; Tommy Alain; Michael Bidinosti; Bruno D Fonseca; Emmanuel Petroulakis; Xiaoshan Wang; Ola Larsson; Anand Selvaraj; Yi Liu; Sara C Kozma; George Thomas; Nahum Sonenberg
Journal:  Science       Date:  2010-05-28       Impact factor: 47.728

Review 9.  Amino acid management in cancer.

Authors:  Zhi-Yang Tsun; Richard Possemato
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

10.  mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.

Authors:  Hakan Cam; John B Easton; Anthony High; Peter J Houghton
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.